Amanda Grippo
Family · Dickson Cty, PANPI 1841622610
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $61,250 of the $86,026 with a category attached, or 71.2%. AbbVie accounts for 93.9% of it on its own, with 35 other manufacturers making up the rest. Among family clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 601 payments — averaging $143.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$81K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
- Galderma Laboratories, L.p.$841
- GSK$596
- QOL Medical, LLC$367
- Takeda Pharmaceuticals U.S.A., Inc.$294
- plus $2K from 30 others
What the payments were for
- Speaking & faculty fees$61,25071%
- Travel & lodging$14,24217%
- Food & beverage$10,53412%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 270 | $80,792 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 84 | $1,032 |
| Galderma Laboratories, L.p. | 61 | $841 |
| GSK | 34 | $596 |
| QOL Medical, LLC | 20 | $367 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $294 |
| Johnson & Johnson | 14 | $257 |
| Merz North America, Inc. | 6 | $225 |
| Novo Nordisk | 12 | $183 |
| Bayer | 11 | $180 |
| Pfizer | 9 | $159 |
| Bristol Myers Squibb | 7 | $110 |
| Lilly USA, LLC | 7 | $107 |
| Revance Therapeutics, Inc. | 2 | $99 |
| Amgen | 6 | $89 |
| Esperion Therapeutics, Inc. | 5 | $70 |
| Abbott | 4 | $61 |
| Gilead | 4 | $56 |
| AstraZeneca | 3 | $47 |
| Eisai Inc. | 3 | $45 |
| Almatica Pharma LLC | 2 | $45 |
| Otsuka America Pharmaceutical, Inc. | 2 | $43 |
| Astellas Pharma US Inc | 2 | $38 |
| Mylan Specialty L.p. | 2 | $37 |
| Madrigal Pharmaceuticals | 2 | $36 |
| Boehringer Ingelheim | 2 | $32 |
| Exact Sciences | 1 | $30 |
| Sanofi-aventis U.S. LLC | 2 | $29 |
| Redhill Biopharma Inc. | 1 | $19 |
| Axonics, Inc. | 1 | $19 |
| Actelion Pharmaceuticals US, Inc. | 1 | $17 |
| Biohaven Pharmaceuticals, Inc. | 1 | $15 |
| Ardelyx, Inc. | 1 | $15 |
| Shield Therapeutics Inc | 1 | $14 |
| Biogen | 1 | $13 |
| Merck | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$86,026 in reported general payments places this provider in the 95th percentile of 4,717 family providers in Pennsylvania.
Other family in Dickson Cty
- Kathleen ScholzPittsburgh$397K
- Shannon FitzgeraldAllison Park$370K
- Stephanie HarshbargerCamp Hill$317K
- Whitney BowlesFort Washington$253K
- Kweilynn GreenePittsburgh$139K
- Kami NestlerWilkes Barre$129K
- Bethany ThomasPhiladelphia$126K
- Margaret RosenzweigPittsburgh$89K
- Patricia HabdasPittsburgh$83K
- Anne CalvaresiPhiladelphia$81K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.